| Spliceosome |
1.89 |
6.96e-2 |
101/150 (67.33%) |
LSM2;PUF60;HSPA2;...
|
| Proteasome |
1.73 |
1.54e-1 |
44/46 (95.65%) |
PSMD2;PSMB8;IFNG;...
|
| Proximal tubule bicarbonate reclamation |
1.66 |
2.12e-1 |
21/23 (91.3%) |
CA2;SLC4A4;PCK1;...
|
| Biosynthesis of unsaturated fatty acids |
1.63 |
2.04e-1 |
21/27 (77.78%) |
ELOVL5;FADS1;ELOVL4;...
|
| Glycosaminoglycan degradation |
1.60 |
1.93e-1 |
19/19 (100%) |
HPSE;HGSNAT;NAGLU;...
|
| Protein digestion and absorption |
1.55 |
2.77e-1 |
78/103 (75.73%) |
SLC7A7;COL4A3;COL1A2;...
|
| Cell adhesion molecules |
1.50 |
3.84e-1 |
118/148 (79.73%) |
CDH2;JAM3;CADM1;...
|
| Hematopoietic cell lineage |
1.50 |
3.37e-1 |
90/99 (90.91%) |
ANPEP;TFRC;KIT;...
|
| Pancreatic secretion |
1.49 |
3.12e-1 |
87/102 (85.29%) |
CA2;SLC4A4;CD38;...
|
| Arrhythmogenic right ventricular cardiomyopathy |
1.44 |
4.30e-1 |
70/77 (90.91%) |
CDH2;DSP;SGCB;...
|
| Viral protein interaction with cytokine and cytokine re... |
1.43 |
4.13e-1 |
84/100 (84%) |
CCL19;CCL4;CCL8;...
|
| Fatty acid elongation |
1.43 |
3.84e-1 |
19/27 (70.37%) |
ELOVL5;ELOVL4;ACOT7;...
|
| Mineral absorption |
1.43 |
3.58e-1 |
48/60 (80%) |
MT1M;FTL;FXYD2;...
|
| Insulin secretion |
1.43 |
3.40e-1 |
75/86 (87.21%) |
STX1A;FXYD2;KCNN2;...
|
| Primary immunodeficiency |
1.42 |
3.40e-1 |
33/38 (86.84%) |
BTK;CD40;ICOS;...
|
| Allograft rejection |
1.40 |
3.47e-1 |
32/38 (84.21%) |
IFNG;CD40;TNF;...
|
| Bile secretion |
1.40 |
3.36e-1 |
68/90 (75.56%) |
CA2;UGT2B28;SLC4A4;...
|
| NF-kappa B signaling pathway |
1.40 |
3.19e-1 |
90/104 (86.54%) |
CCL19;BTK;BCL2A1;...
|
| Salivary secretion |
1.38 |
3.51e-1 |
76/93 (81.72%) |
CALML5;CD38;FXYD2;...
|
| Inflammatory bowel disease |
1.38 |
3.47e-1 |
58/65 (89.23%) |
GATA3;SMAD2;STAT1;...
|
| Asthma |
1.36 |
3.54e-1 |
25/31 (80.65%) |
CD40;TNF;IL9;...
|
| Vitamin digestion and absorption |
1.35 |
3.58e-1 |
17/24 (70.83%) |
SLC19A2;LMBRD1;PNLIP;...
|
| Selenocompound metabolism |
1.35 |
3.67e-1 |
11/17 (64.71%) |
CTH;KYAT3;SEPHS2
|
| Renin-angiotensin system |
1.34 |
3.71e-1 |
20/23 (86.96%) |
ANPEP;AGTR1;KLK1;...
|
| Transcriptional misregulation in cancer |
1.34 |
3.61e-1 |
158/192 (82.29%) |
BCL2A1;MMP9;MYCN;...
|
| Intestinal immune network for IgA production |
1.32 |
4.01e-1 |
38/48 (79.17%) |
CD40;ICOS;CXCL12;...
|
| Systemic lupus erythematosus |
1.31 |
3.95e-1 |
45/135 (33.33%) |
IFNG;C7;CD40;...
|
| Endocrine and other factor-regulated calcium reabsorpti... |
1.31 |
3.88e-1 |
49/53 (92.45%) |
AP2M1;FXYD2;PRKCB;...
|
| Epstein-Barr virus infection |
1.30 |
4.08e-1 |
189/202 (93.56%) |
CYCS;BTK;PSMD2;...
|
| Cortisol synthesis and secretion |
1.27 |
4.72e-1 |
58/65 (89.23%) |
CYP11A1;ITPR3;AGTR1;...
|
| Alanine, aspartate and glutamate metabolism |
-1.10 |
7.28e-1 |
27/37 (72.97%) |
ASPA;GOT2;GLS2;...
|
| Non-homologous end-joining |
-1.11 |
7.19e-1 |
11/13 (84.62%) |
LIG4;POLL;RAD50;...
|
| Human papillomavirus infection |
-1.11 |
7.02e-1 |
284/331 (85.8%) |
CCND1;PPP2R3A;LAMC1;...
|
| Renin secretion |
-1.12 |
6.95e-1 |
61/69 (88.41%) |
PLCB4;PLCB2;ITPR1;...
|
| Wnt signaling pathway |
-1.12 |
7.06e-1 |
124/166 (74.7%) |
RAC2;CCND1;TBL1XR1;...
|
| Signaling pathways regulating pluripotency of stem cell... |
-1.12 |
7.02e-1 |
110/143 (76.92%) |
PCGF2;BMPR2;ACVR2B;...
|
| Fat digestion and absorption |
-1.13 |
7.03e-1 |
35/43 (81.4%) |
PLA2G10;ABCA1;ACAT1;...
|
| Pantothenate and CoA biosynthesis |
-1.13 |
7.11e-1 |
14/21 (66.67%) |
BCAT1;PANK3;ALDH3A2;...
|
| Salmonella infection |
-1.13 |
7.22e-1 |
198/249 (79.52%) |
RPS3;TCF7;GSDMD;...
|
| Glycerolipid metabolism |
-1.13 |
7.26e-1 |
44/61 (72.13%) |
ALDH3A2;AGPAT3;LIPC;...
|
| Neurotrophin signaling pathway |
-1.14 |
7.21e-1 |
107/119 (89.92%) |
RAP1A;CAMK2B;RPS6KA3;...
|
| Tight junction |
-1.14 |
7.23e-1 |
130/169 (76.92%) |
CLDN8;PPP2CA;PARD6A;...
|
| Vasopressin-regulated water reabsorption |
-1.15 |
7.07e-1 |
40/44 (90.91%) |
DCTN4;CREB3L1;RAB5B;...
|
| PI3K-Akt signaling pathway |
-1.15 |
7.16e-1 |
317/354 (89.55%) |
ATF2;CCND1;PPP2R3A;...
|
| TNF signaling pathway |
-1.15 |
7.21e-1 |
103/112 (91.96%) |
CEBPB;ATF2;IKBKG;...
|
| Malaria |
-1.21 |
7.22e-1 |
44/50 (88%) |
SDC1;ITGB2;TGFB3;...
|
| Osteoclast differentiation |
-1.21 |
7.24e-1 |
117/127 (92.13%) |
PIK3R1;MAPK14;MAP2K1;...
|
| Adherens junction |
-1.22 |
7.03e-1 |
63/71 (88.73%) |
SORBS1;RAC2;TCF7L1;...
|
| Autophagy |
-1.22 |
7.17e-1 |
113/169 (66.86%) |
STX17;SQSTM1;IGBP1;...
|
| FoxO signaling pathway |
-1.23 |
7.27e-1 |
118/131 (90.08%) |
MDM2;TGFB2;CAT;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.25 |
6.66e-1 |
62/70 (88.57%) |
IKBKG;CXCR1;CASP3;...
|
| Colorectal cancer |
-1.25 |
6.86e-1 |
84/86 (97.67%) |
TGFB2;RAC2;CCND1;...
|
| Hedgehog signaling pathway |
-1.25 |
7.07e-1 |
43/56 (76.79%) |
GLI3;CSNK1G1;PTCH1;...
|
| Estrogen signaling pathway |
-1.25 |
7.26e-1 |
119/137 (86.86%) |
KRT20;RARA;ATF2;...
|
| Axon guidance |
-1.47 |
6.73e-1 |
151/182 (82.97%) |
ABL1;NCK1;BMPR2;...
|
| Fc gamma R-mediated phagocytosis |
-1.58 |
3.50e-1 |
79/97 (81.44%) |
ARPC3;ARF6;ASAP3;...
|
| Glyoxylate and dicarboxylate metabolism |
-1.61 |
3.47e-1 |
23/30 (76.67%) |
CAT;HYI;DLD;...
|
| One carbon pool by folate |
-1.69 |
2.11e-1 |
15/20 (75%) |
AMT;ALDH1L1;GART;...
|
| Mucin type O-glycan biosynthesis |
-1.73 |
2.11e-1 |
20/36 (55.56%) |
C1GALT1;ST3GAL2;B3GNT3;...
|
| Other types of O-glycan biosynthesis |
-1.82 |
1.10e-1 |
29/47 (61.7%) |
GALNT11;PLOD3;OGT;...
|
